Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome

被引：13

作者：

Zeidan, Amer M. ^{[1
,2
]}

Borate, Uma ^{[3
]}

Pollyea, Daniel A. ^{[4
]}

Brunner, Andrew M. ^{[5
]}

Roncolato, Fernando ^{[6
]}

Garcia, Jacqueline S. ^{[7
]}

Filshie, Robin J. ^{[8
]}

Odenike, Olatoyosi ^{[9
,10
]}

Watson, Anne-Marie ^{[11
]}

Krishnadasan, Ravi ^{[12
]}

Bajel, Ashish ^{[13
,14
]}

Naqvi, Kiran ^{[15
]}

Zha, Jiuhong ^{[16
]}

Hogdal, Leah ^{[16
]}

Zhou, Ying ^{[16
]}

Hoffman, David ^{[16
]}

Kye, Steve ^{[16
]}

Garcia-Manero, Guillermo ^{[17
]}

机构：

[1] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06510 USA

[2] Yale Canc Ctr, New Haven, CT USA

[3] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Knight Canc Inst, Portland, OR 97201 USA

[4] Univ Colorado, Dept Hematol, Aurora, CO USA

[5] Massachusetts Gen Hosp, Ctr Leukemia, Boston, MA 02114 USA

[6] Univ New South Wales, Dept Hematol, Sydney, NSW, Australia

[7] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[8] St Vincents Hosp Melbourne, Dept Hematol, Melbourne, Vic, Australia

[9] Univ Chicago Med, Chicago, IL USA

[10] Comprehens Canc Ctr, Chicago, IL USA

[11] Liverpool Hosp, Dept Haematol, Liverpool, Merseyside, Australia

[12] Univ Arizona, Canc Ctr, Tucson, AZ USA

[13] Peter MacCallum Canc Ctr, Dept Clin Haematol, Melbourne, Vic, Australia

[14] Royal Melbourne Hosp, Melbourne, Vic, Australia

[15] Genentech Inc, San Francisco, CA 94080 USA

[16] AbbVie Inc, N Chicago, IL USA

[17] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-145646

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

537

引用

页数：6

共 50 条

[41] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
Che-Hung Lin
Su-Peng Yeh
Tze-Yi Lin
Annals of Hematology, 2015, 94 : 1925 - 1926
[42] The Combination of Gemtuzumab Ozogamicin and Azacitidine in the Treatment of Relapsed and Refractory AML
Budaeva, Irina
Zaytsev, Daniil
Shatilova, Alexina
Tochenaya, Elena
Petrov, Alexey
Vabishchevich, Raisa
Motorin, Dmitriy
Badaev, Renat
Ivanov, Vladimir
Bogdanov, Konstantin
Mirolyubova, Yulia
Nikulina, Tatiana
Alekseeva, Yulia
Zaritskey, Andrey
Girshova, Larisa
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S301 - S301
[43] Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study
Petit, Cassandre
Higue, Jules
Acheaibi, Ziyad
Gilhodes, Julia
Hospital, Marie-Anne
Devillier, Raynier
Bewersdorf, Jan
Goldberg, Aaron D.
Pigneux, Arnaud
Vey, Norbert
Recher, Christian
Stahl, Maximilian
Bertoli, Sarah
Dumas, Pierre-Yves
Garciaz, Sylvain
AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (05) : 906 - 908
[44] Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL
D'Rozario, James
Bennett, Samuel K.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 12
[45] A Phase Ib/II Study Evaluating Navitoclax after Failure of Hypomethylating Agent and Venetoclax for Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome
Keiffer, Gina
Meyer, Sara E.
Eischen, Christine
Outschoorn, Ubaldo Martinez
Alpdogan, Onder
Binder, Adam F.
Porcu, Pierluigi
Wilde, Lindsay
Kasner, Margaret
Palmisiano, Neil
BLOOD, 2023, 142
[46] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
Nam, S.
Lim, T.
Kim, B.
HAEMATOLOGICA, 2013, 98 : 588 - 588
[47] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
Nam, Seung-Hyun
Lim, Taekyu
Kim, Bong-Seog
BLOOD, 2012, 120 (21)
[48] Poor Outcome of Patients with Myelodysplastic Syndrome (MDS) After Azacitidine Treatment Failure
Lin, Karen
Reljic, Tea
Kumar, Ambuj
Lancet, Jeffrey E.
List, Alan F.
Komrokji, Rami S.
BLOOD, 2010, 116 (21) : 1199 - 1200
[49] FLAG-IDA/VENETOCLAX IS ASSOCIATED WITH HIGHER REMISSION RATES AND IMPROVED POST-TRANSPLANT SURVIVAL COMPARED TO VENETOCLAX/AZACITIDINE IN RELAPSED/REFRACTORY AML PATIENTS
Klyuchnikov, Evgeny
Badbaran, Anita
Massoud, Radwan
Steiner, Normann
Freiberger, Petra
Modemann, Franziska
Schoenrock, Martin
Cichutek, Sophia
Fiedler, Walter
Peeck, Micha
Gagelmann, Nico
Wolschke, Christine
Ayuk, Francis
Bacher, Ulrike
Kroeger, Nicolaus
BONE MARROW TRANSPLANTATION, 2024, 59 : 153 - 153
[50] Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience
Kantarjian, HM
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2415 - 2416

← 1 2 3 4 5 →